H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
Researchers examine the impact of human movement on disease spread

Researchers examine the impact of human movement on disease spread

Can amodiaquine short circuit this pandemic?

Can amodiaquine short circuit this pandemic?

Research compares T cell responses to SARS-CoV-2 and influenza

Research compares T cell responses to SARS-CoV-2 and influenza

Dozens of U.S. hospitals poised to defy FDA’s directive on COVID plasma

Dozens of U.S. hospitals poised to defy FDA’s directive on COVID plasma

Health officials worry nation is not ready for COVID-19 vaccine

Health officials worry nation is not ready for COVID-19 vaccine

Silicon nitride shows potent SARS-CoV-2 neutralization capability

Silicon nitride shows potent SARS-CoV-2 neutralization capability

Pigs appear to be immune to SARS-CoV-2

Pigs appear to be immune to SARS-CoV-2

COVID-19 pandemic as severe as 1918 influenza pandemic

COVID-19 pandemic as severe as 1918 influenza pandemic

How have non-pharmaceutical interventions helped in COVID-19?

How have non-pharmaceutical interventions helped in COVID-19?

Study: Drinking honeysuckle decoction accelerates the negative conversion of COVID-19 patients

Study: Drinking honeysuckle decoction accelerates the negative conversion of COVID-19 patients

Humans promote diseases from the animal kingdom

Humans promote diseases from the animal kingdom

Oxford Nanopore Technologies partners with UK Government to roll out LamPORE, a new generation of COVID-19 test

Oxford Nanopore Technologies partners with UK Government to roll out LamPORE, a new generation of COVID-19 test

Meta-analysis shows 57% mortality reduction with convalescent plasma in COVID-19

Meta-analysis shows 57% mortality reduction with convalescent plasma in COVID-19

Scientists develop human lung organoids to study SARS-CoV-2 infection

Scientists develop human lung organoids to study SARS-CoV-2 infection

Antimalarial drug shows in vitro activity against SARS-CoV-2 and flu viruses

Antimalarial drug shows in vitro activity against SARS-CoV-2 and flu viruses

Fighting a pandemic is 500 times more expensive than the costs of preventive efforts

Fighting a pandemic is 500 times more expensive than the costs of preventive efforts

Findings show promise for developing vaccines against multiple strains of flu, including SARS-CoV-2

Findings show promise for developing vaccines against multiple strains of flu, including SARS-CoV-2

Next showdown in Congress: Protecting workers vs. protecting employers in the pandemic

Next showdown in Congress: Protecting workers vs. protecting employers in the pandemic

New clinical trial to assess safety and efficacy of convalescent plasma to prevent COVID-19

New clinical trial to assess safety and efficacy of convalescent plasma to prevent COVID-19

Scientists recommend a decentralized biosurveillance system to protect from diseases

Scientists recommend a decentralized biosurveillance system to protect from diseases